Press Releases :: Nighthawk Biosciences, Inc. (NHWK)

Feb 02, 2022 4:05pm EST

Heat Biologics Announces Planned Transfer to the NYSE American

Jan 31, 2022 7:30am EST

Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human Services

Jan 12, 2022 8:00am EST

Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110

Dec 21, 2021 7:30am EST

Heat Biologics Announces Planned Acquisition of Elusys Therapeutics

Nov 30, 2021 7:30am EST

Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats

Nov 10, 2021 4:05pm EST

Heat Biologics Provides Third Quarter 2021 Business Update

Oct 06, 2021 7:30am EDT

Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy

Sep 15, 2021 7:30am EDT

Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

Sep 09, 2021 8:30am EDT

Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 30, 2021 7:30am EDT

Heat Biologics to Provide Corporate Update

rss_feed News RSS

OUR ECOSYSTEM